Oncology
0 drugs are in development for Melanoma Stage III.
- Companies
- 0
- Clinical trials
- 11
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Melanoma Stage III pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Melanoma Stage III context
Oncology·MeSH: Melanoma (D008545)
Narrower concept of MeSH descriptor Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
Frequently asked questions
How many clinical trials target Melanoma Stage III?
There are 11 clinical trials targeting Melanoma Stage III tracked by BioSniper.
What is the prevalence of Melanoma Stage III?
The estimated prevalence of Melanoma Stage III is approximately 75.0 per 100,000 population.